Osimertinib in Resected EGFR-Mutated Non–Small-Cell Lung Cancer

Original Article

Y.-L. Wu, M. Tsuboi, J. He, T. John, C. Grohe, M. Majem, J.W. Goldman, K. Laktionov, S.-W. Kim, T. Kato, H.-V. Vu, S. Lu, K.-Y. Lee, C. Akewanlop, C.-J. Yu, F.d. Marinis, L. Bonanno, M. Domine, F.A. Shepherd, L. Zeng, R. Hodge, A. Atasoy, Y. Rukazenkov, and R.S. Herbst

N Engl J Med 2020;383:1711-1723

Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
10/28/2020
Course expires: 
10/29/2022

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Course closed

This course closed on Saturday, October 29, 2022 - 11:59pm.